AbClon

Company

Also known as: AbClon

Company Profile

AbClon is a Korean biotechnology company focused on antibody drug research and development, including CAR-T and antibody platforms for oncology and immune diseases.

Website: https://www.abclon.com
Headquarters: Seoul, South Korea
Founded: 2010
Stock Ticker: KOSDAQ:174900

Related News

Korean Biotechs to Present Next-Gen Cancer Therapies at AACR Meeting

Apr 08, 2026

Korean biotech firms will present next-generation cancer therapies at the AACR meeting, including CAR-T platforms for solid tumors, mRNA-based treatments, radiopharmaceuticals, and bispecific antibody ADCs. Companies like AbClon, Verismo Therapeutics, Hanmi Pharmaceutical, and SK Biopharmaceuticals will showcase their latest research.

In Vivo CAR-T Technology and Community Delivery Expand Cancer Treatment Access

Feb 28, 2026

Next-generation in vivo CAR-T therapy enables cancer treatment with a single injection, while new Texas legislation and community-based delivery models expand patient access to this advanced cellular therapy.